AXSM vs. CORT

In the year-to-date period, AXSM achieves a 52.58% return, which is significantly higher than CORT's 29.17% return.

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

This table presents a comparison of risk-adjusted performance metrics for Axsome Therapeutics, Inc. (AXSM) and Corcept Therapeutics Incorporated (CORT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current AXSM Sharpe Ratio is 0.82, which is lower than the CORT Sharpe Ratio of 3.86. The chart below compares the historical Sharpe Ratios of AXSM and CORT, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Neither AXSM nor CORT has paid dividends to shareholders.

The maximum AXSM drawdown since its inception was -86.65%, smaller than the maximum CORT drawdown of -94.28%. Use the drawdown chart below to compare losses from any high point for AXSM and CORT. For additional features, visit the drawdowns tool.

Axsome Therapeutics, Inc. (AXSM) and Corcept Therapeutics Incorporated (CORT) have volatilities of 21.51% and 21.21%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.

This section allows you to compare key financial metrics between Axsome Therapeutics, Inc. and Corcept Therapeutics Incorporated. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.